FDA OKs prefilled syringe option for Regeneron's Eylea
he FDA approves a 2 mg single-dose prefilled syringe formulation of Regeneron Pharmaceuticals' (NASDAQ:REGN) Eylea (aflibercept).
https://seekingalpha.com/news/3490985-fda-oks-prefilled-syringe-option-regenerons-eylea
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.